Abcam announces successful acquisition of Expedeon’s Proteomics and Immunology business, enhancing its conjugation capability

Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon’s Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1st January 2020.
Read More

Leave a comment